CIK 0001287098 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
MAXCYTE, INC.
Sign in to watch- Ticker
- MXCT
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 522210438
- Phone
- 301-517-5556
- Business address
- 9713 KEY WEST AVENUE,, SUITE 400, ROCKVILLE, MD, 20850
- Former names
- MAXCYTE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 42 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-10 | Doerfler Douglas President and CEO | Sale 10b5-1 | −100 | $5.00 | $500 | 333,197 |
| 2023-04-10 | Doerfler Douglas President and CEO | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −100 | 339,980 | ||
| 2023-04-06 | Ross Thomas M. EVP, Global Sales & Marketing | Option exercise 10b5-1 | +27,193 | $2.14 | $58K | 27,193 |
| 2023-04-06 | Ross Thomas M. EVP, Global Sales & Marketing | Sale 10b5-1 | −27,193 | $5.03 | $137K | 0 |
| 2023-04-06 | Ross Thomas M. EVP, Global Sales & Marketing | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −27,193 | 28,002 | ||
| 2023-04-06 | Doerfler Douglas President and CEO | Option exercise 10b5-1 | +27,862 | $0.04 | $1K | 361,059 |
| 2023-04-06 | Doerfler Douglas President and CEO | Sale 10b5-1 | −27,862 | $5.03 | $140K | 333,197 |
| 2023-04-06 | Doerfler Douglas President and CEO | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −27,862 | 340,080 | ||
| 2023-04-05 | Ross Thomas M. EVP, Global Sales & Marketing | Option exercise 10b5-1 | +6,967 | $2.14 | $15K | 6,967 |
| 2023-04-05 | Ross Thomas M. EVP, Global Sales & Marketing | Sale 10b5-1 | −6,967 | $5.00 | $35K | 0 |
| 2023-04-05 | Ross Thomas M. EVP, Global Sales & Marketing | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −6,967 | 55,195 | ||
| 2023-04-05 | Doerfler Douglas President and CEO | Option exercise 10b5-1 | +6,961 | $0.04 | $278 | 340,158 |
| 2023-04-05 | Doerfler Douglas President and CEO | Sale 10b5-1 | −6,961 | $5.00 | $35K | 333,197 |
| 2023-04-05 | Doerfler Douglas President and CEO | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −6,961 | 367,942 | ||
| 2023-04-04 | Ross Thomas M. EVP, Global Sales & Marketing | Option exercise 10b5-1 | +7,266 | $2.14 | $16K | 7,266 |
| 2023-04-04 | Ross Thomas M. EVP, Global Sales & Marketing | Sale 10b5-1 | −7,266 | $5.03 | $37K | 0 |
| 2023-04-04 | Ross Thomas M. EVP, Global Sales & Marketing | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −7,266 | 62,162 | ||
| 2023-04-04 | Doerfler Douglas President and CEO | Option exercise 10b5-1 | +7,470 | $0.04 | $299 | 340,667 |
| 2023-04-04 | Doerfler Douglas President and CEO | Sale 10b5-1 | −7,470 | $5.03 | $38K | 333,197 |
| 2023-04-04 | Doerfler Douglas President and CEO | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −7,470 | 374,903 |
Page 13 of 15 · 282 trades